DJIA 16,563.30 -317.06 -1.88%
NASDAQ 4,369.77 -93.13 -2.09%
S&P 500 1,930.67 -39.40 -2.00%
market minute promo

Amarin Corp plc (ADR) (NASDAQ: AMRN)

1.80 0.21 (13.21%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AMRN $1.80 13.21%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.73
Previous Close $1.59
Daily Range $1.66 - $1.82
52-Week Range $1.28 - $7.40
Market Cap $311.2M
P/E Ratio -1.59
Dividend (Yield) $0.00 (0.0%)
Volume 14,863,639
Average Daily Volume 1,658,853
Current FY EPS -$0.57

Sector

Healthcare

Industry

Drugs

Amarin Corp plc (ADR) (AMRN) Description

The Company is engaged in the research, development and commercialization of novel drugs for the treatment of central nervous system disorders. Website: http://www.amarincorp.com/

News & Commentary

Two Years Less Exclusivity Is the Least of Amarin's Issues

Amarin's patents holding up in court and being able to compete with GlaxoSmithKline's Lovaza for patients are much bigger deals.

Amarin Moves Higher On Speculation Of Special Protocol Assessment

Amarin Shocker: There's a Reason to be Bullish Right Now

Amarin: Will The Lamb Of Ireland Bleat Or The Lion Of The People Roar?

Shire Retreats for Second Day Since Abbvie's Revised Bid as European ADRs Decline; Portugal Telecom

Shire Retreats for Second Day Since Abbvie's Revised Bid as European ADRs Decline; Portugal Telecom Gains

European ADRs Post Broad Declines After European Markets Weaken on German, U.K. Economic Data

Basket Of Biotech Bargains To Buy And Hold

Amarin Scrapes The Bottom Of The Barrel

Amarin Leads Gains in European ADRs After Favorable Journal Article; Nokia Down on Amazon.com Phone

Top Performing Industries For June 12, 2014

Stagnant Sales An Ominous Sign For Amarin

See More AMRN News...

AMRN's Top Competitors

AMRN $1.80 (13.21%)
Current stock: AMRN
JNJ $100.09 (-2.16%)
Current stock: JNJ
NVS $86.94 (-1.70%)
Current stock: NVS
RHHBY $36.33 (-1.36%)
Current stock: RHHBY